FdaApplication

ANDA 210954

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS CO GMBH
application_typeANDA
approval_date2019-07-02

Products (3)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN333MGTABLET, DELAYED RELEASE;ORAL
ERYTHROMYCINERYTHROMYCIN250MGTABLET, DELAYED RELEASE;ORAL
ERYTHROMYCINERYTHROMYCIN500MGTABLET, DELAYED RELEASE;ORAL

3 products